Chugai Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	78,994	73,690	70,756	56,409	39,312	46,901
Market Cap Growth	14.66%	4.15%	25.44%	43.49%	-16.18%	-34.54%
Enterprise Value	73,651	68,897	65,562	52,437	35,443	43,872
Last Close Price	47.55	44.29	40.22	31.75	21.83	25.53
PE Ratio	33.51	31.26	29.74	27.00	14.80	20.27
PS Ratio	11.56	10.78	9.84	7.91	4.40	6.14
PB Ratio	7.18	6.70	6.06	5.41	3.89	5.17
P/TBV Ratio	7.38	6.88	6.11	5.47	3.96	5.27
P/FCF Ratio	46.91	43.76	29.00	26.01	30.53	28.74
P/OCF Ratio	37.65	35.12	25.73	21.44	22.70	21.96
EV/Sales Ratio	10.74	10.08	9.12	7.35	3.97	5.75
EV/EBITDA Ratio	21.69	20.57	18.60	17.35	8.85	12.69
EV/EBIT Ratio	22.88	21.49	19.69	18.60	9.37	13.62
EV/FCF Ratio	43.74	40.91	26.87	24.17	27.52	26.89
Debt / Equity Ratio	-	-	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	-	0.02	0.03	0.02	0.04
Debt / FCF Ratio	-	-	0.03	0.04	0.08	0.08
Asset Turnover	0.54	0.54	0.56	0.59	0.74	0.72
Inventory Turnover	1.41	1.41	1.32	1.46	1.90	1.72
Quick Ratio	3.46	3.46	4.59	3.68	2.40	2.53
Current Ratio	4.24	4.24	5.53	4.74	3.15	3.25
Return on Equity (ROE)	22.10%	22.10%	21.96%	21.34%	28.67%	27.95%
Return on Assets (ROA)	15.77%	15.77%	16.36%	14.44%	19.56%	19.01%
Return on Invested Capital (ROIC)	41.72%	43.67%	42.57%	35.09%	45.09%	45.33%
Return on Capital Employed (ROCE)	28.70%	28.70%	28.30%	26.70%	36.90%	34.80%
Earnings Yield	2.98%	3.20%	3.36%	3.70%	6.76%	4.93%
FCF Yield	2.13%	2.28%	3.45%	3.84%	3.28%	3.48%
Dividend Yield	3.23%	1.50%	1.50%	1.62%	2.54%	2.27%
Payout Ratio	68.99%	68.99%	34.40%	40.43%	36.91%	32.56%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	3.23%	1.49%	1.49%	1.61%	2.53%	2.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.